clinical study of Efficacy Evaluation of Olipass RNA RS Samgongil OLB Cream for improving skin elasticity and other multi-items on humans and skin primary irritation test

Global Medical Research Center0 个研究点目标入组 22 人开始时间: 待定最近更新: 2022年10月24日

试验速览

暂无简介。

•1) Women aged 30 to 59 with wrinkles
•2) A person who voluntarily signed consent after being fully explained about the purpose and content of the test
•3) Those who can follow-up during the test period
•4) A healthy person without acute or chronic physical diseases including skin diseases

•1) Pregnant or lactating women and women of childbearing age who do not agree to the contraceptive method specified in the protocol
•2) If there is a lesion in the test site
•3) If you have an infectious skin disease
•4) If you have allergies or hypersensitivity
•5) In case of irritation from cosmetics, pharmaceuticals, and daily exposure to light
•6) If you have received systemic steroids or phototherapy within 1 month of participating in the test
•7) If you have received skin treatment (scaling/botox/filler/laser/tattoo) within 3 months of participating in the test
•8) If a drug with a similar function was used in the study site within 3 months before the start of the study
•9) If you have a mental illness, mental retardation disorder, etc.
•10) In addition to the above, if it is judged that it is difficult to conduct a human test by the responsible researcher or the person in charge of the study

发起方